Year Founded
2010
Ownership
Private
Employees
~50
Stage
Commercial
Modalities
Medical devicesHydrogel-based drug deliveryPolymer-based drug delivery

Imbed Biosciences General Information

Company has FDA-cleared products for wound care. Recent IDE approval for clinical trial of silver-gallium matrix for donor site wounds. Over 100,000 units of Microlyte Matrix used in complex wounds over last 12 months.

Contact Information

Website
Primary Industry
Medical Device
Corporate Office
Madison, Wisconsin
United States

Drug Pipeline

Microlyte Matrix
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Imbed Biosciences's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Imbed Biosciences Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Imbed Biosciences's complete valuation and funding history, request access »

Imbed Biosciences Investors

Not explicitly listed; likely private investors.
Investor Type: Venture Capital
Holding: Minority